分类: health

  • Rehab robots in UAE offer new hope for stroke and spinal injury patients

    Rehab robots in UAE offer new hope for stroke and spinal injury patients

    Aster DM Healthcare, a major UAE healthcare provider, is pioneering a revolutionary approach to neurological and pediatric rehabilitation through the deployment of over 21 FDA-approved robotic systems across its facilities this year. These advanced medical technologies represent a significant leap forward in treating stroke survivors, spinal injury patients, and children with developmental conditions.

    The robotic systems, described by Managing Director and Group CEO Alisha Moopen as ‘next level’ technology, work in collaboration with neurosurgeons and physiotherapists to retrain the brain by rebuilding damaged neural connections. ‘There are people who have just given up complete hope after certain injuries,’ Moopen stated. ‘There is a chance that they will be able to walk again.’

    Among the most groundbreaking innovations is the world’s first pediatric rehabilitation robot scheduled for introduction in Dubai later this year. This specialized technology will support children with ADHD and other developmental challenges through integrated brain mapping, virtual reality immersion therapy, and targeted neural stimulation. Moopen emphasized that this advancement ‘will change the way we talk about child behaviors, child psychology and child development issues.’

    Concurrent with its technological expansion, Aster DM Healthcare is significantly growing its physical infrastructure. The group will open two new multi-specialty hospitals in Dubai’s Studio City and Discovery Gardens areas, adding over 250 beds to their current approximately 920-bed UAE capacity. Additionally, plans are underway to expand Aster Hospital in Al Qusais with 122 operational beds.

    Moopen attributed this expansion to demographic shifts rather than increased illness rates. ‘It’s not that people are getting sicker; it’s that people are living longer,’ she explained. ‘When your length of life has increased, the requirement for healthcare increases.’ This longevity trend has created new demand for geriatric care services, with the UAE seeing more retirees choosing to settle in the country.

    Complementing these developments, Aster launched the Thrive system—a comprehensive preventive health assessment that tests for 100 biomarkers including blood health, cardiac function, metabolism, hormones, inflammation, and nutritional status. This proactive health monitoring platform will integrate with major wearable devices and the myAster app, enabling physicians to provide personalized insights and preventive recommendations for long-term wellbeing.

  • Ban on mercury thermometers sparks panic buying and market transformation

    Ban on mercury thermometers sparks panic buying and market transformation

    A nationwide prohibition on mercury thermometer manufacturing has triggered unprecedented market dynamics across China, revealing deep public attachment to the traditional medical device while accelerating the healthcare sector’s digital transformation. The ban, effective January 1, 2026, implemented under China’s commitments to the Minamata Convention on Mercury, has sparked both consumer anxiety and industry innovation.

    Pharmaceutical retailers from Wuhan to Beijing report extraordinary buying surges, with prices escalating from approximately $0.70 to over $4 per unit within days. Pharmacy owner Tan Enping described implementing purchase limits as inventories dwindled: “Even with rationing of two thermometers per customer, our supplies will vanish rapidly due to overwhelming demand.”

    The phenomenon stems from generations of trust in mercury-based thermometry, with many households considering them irreplaceable despite recognized hazards. Public health expert Su Jing from Tsinghua University clarified this represents “an inevitable measure” for environmental and health protection, noting mercury’s documented risks to neurological and renal systems when devices break and release toxic vapor.

    Meanwhile, healthcare institutions have already completed their transition to digital alternatives. Wuhan No. 9 Hospital head nurse Wu Yin confirmed full departmental adoption of electronic thermometers five years ago, highlighting advantages including automated data recording and reduced infection transmission.

    Manufacturers like Yuyue Medical Equipment & Supply Company have substantially pivoted toward electronic devices, with mercury products now constituting a minor segment of their operations. Contemporary alternatives encompass digital oral thermometers and infrared temporal/auricular models employing advanced sensor calibration systems that meet clinical accuracy standards.

    The policy specifically prohibits manufacturing rather than possession or sale of existing inventory, creating an interim period where education about proper mercury cleanup procedures—including ventilation, protective equipment, and hazardous waste disposal—has become a public health priority.

  • Non-medical sale of GLP-1 weight-loss drugs on the rise; UAE expert warns of risks

    Non-medical sale of GLP-1 weight-loss drugs on the rise; UAE expert warns of risks

    The rapid commercialization of GLP-1 weight-loss medications through non-medical channels is raising significant safety concerns among healthcare professionals in the UAE. What began as strictly controlled pharmaceutical treatments have now entered the consumer marketplace through subscription services, wellness clinics, and even home service apps.

    Dr. Ali Hashemi, CEO of metabolic.health (GluCare), emphasizes that the medications themselves aren’t problematic when properly administered. ‘When prescribed appropriately with thorough screening and follow-up, they represent among the most significant advancements in metabolic health we’ve encountered,’ he stated. The danger emerges when these powerful drugs are treated as convenience products rather than serious medical interventions.

    The acceleration of GLP-1 adoption, fueled by social media visibility and dramatic weight-loss results, has created a market ripe for exploitation. These medications are now being marketed through unconventional channels including aesthetic clinics, IV drip services, and online subscription platforms with minimal clinical oversight. Recently, consumer apps primarily known for home cleaning and spa services have begun promoting obesity treatments alongside their常规 services.

    Medical professionals report seeing patients experiencing preventable complications from improperly managed GLP-1 regimens. These aren’t rare medical anomalies but practical management failures: excessively rapid dosage escalation, insufficient education on side-effect management, inadequate screening for contraindications, and absent follow-up care. Consequences include severe nausea, vomiting, dehydration, constipation, fatigue, and associated anxiety from feeling unwell and unsupported.

    Beyond immediate side effects, experts highlight underreported risks such as significant muscle loss. Dr. Hashemi notes that without proper emphasis on protein intake, resistance training, and lean mass preservation, patients may achieve lower numbers on the scale while actually becoming weaker and less healthy.

    Healthcare management specialist Dr. Sami Mohammed Yesuf warns that the primary risk resides not in the medications themselves but in delivery models that fragment care. ‘Obesity is a complex, chronic disease requiring comprehensive management,’ he explained. ‘When GLP-1 therapy is delivered outside proper medical frameworks, critical risks can be overlooked.’

    The commercialization trend risks transforming obesity medicine from a clinical discipline into an add-on service, potentially leading to increased side effects, treatment discontinuation, weight rebound, and eroded public trust. Additional concerns include inconsistent medication sourcing when drugs are supplied outside regulated pharmacy channels.

    Responsible GLP-1 programs, according to experts, must include proper medical screening, clear titration plans, proactive side-effect management, structured follow-up (especially within the first 8-12 weeks), muscle preservation strategies, and long-term maintenance planning. Patients are advised to inquire directly about prescription sources, side-effect management protocols, follow-up frequency, and medication origins before beginning treatment.

    While innovation and improved access are welcomed, medical professionals stress that accountability remains non-negotiable. The current situation presents a critical juncture where clinical discipline must match commercial demand to prevent lasting damage to patient trust and outcomes.

  • UAE’s first road-rail ambulance promises faster access to remote areas

    UAE’s first road-rail ambulance promises faster access to remote areas

    The United Arab Emirates has unveiled a groundbreaking medical response vehicle capable of operating on both roadways and railway tracks, marking a significant advancement in emergency healthcare accessibility for remote desert areas. This innovative ambulance, domestically manufactured by safety solutions provider Naffco, integrates conventional American ambulance specifications with an adaptable rail gear mechanism inspired by locomotive engineering.

    The development coincides with the rapid expansion of the UAE-Saudi railway infrastructure, centrally supported by Etihad Rail’s 900-kilometer network connecting Ghuweifat at the Saudi border to Fujairah on the eastern coast. This strategic alignment enables the specialized ambulances to leverage emerging rail connections for reaching patients in geographically challenging territories where traditional emergency vehicles face operational limitations.

    According to Mohammed Abdul Jabbar, Sales Account Manager at Naffco FZCO, the vehicle represents a fusion of international standards and localized innovation. “We’ve engineered a dual-mode ambulance that transitions seamlessly between road and rail operations,” Jabbar explained during the World Health Expo demonstration. “When approaching railway tracks, the front-mounted rail gear system engages, elevating the tires and converting the vehicle into a track-compatible emergency transport.”

    The technical specifications reveal a comprehensive medical response unit equipped with advanced life support systems including oxygen and vacuum apparatus, DC/AC power outlets, automated external defibrillators, portable ventilators, and comprehensive trauma management kits. The interior configuration features strategically positioned medical cabinets with sliding Plexiglas, multi-access storage compartments, and specialized containment systems for medical waste.

    Notably, the manufacturing process emphasizes local production with selective international component integration. Naffco sources vehicle chassis from Ford and imports the specialized rail mechanism from European suppliers, subsequently engineering the complete emergency response system within UAE facilities.

    This innovation arrives as the Etihad Rail passenger service prepares to connect 11 stations across all seven emirates through phased inaugurations throughout the year. The broader Gulf Cooperation Council railway initiative, targeting full connectivity among six Gulf nations by 2030, further amplifies the potential for cross-border emergency medical cooperation through this pioneering transportation technology.

  • Study shows TCM raised live birth rates in over 35s

    Study shows TCM raised live birth rates in over 35s

    A groundbreaking clinical study published in Nature Communications has demonstrated significant fertility benefits for women of advanced maternal age using Traditional Chinese Medicine (TCM). The January publication marks the first time the prestigious journal has featured clinical research on TCM applications in reproductive medicine.

    The randomized clinical trial, conducted across 12 tertiary hospitals in China, evaluated Zishen Yutai pills developed by Guangzhou Baiyunshanzhongyi Pharmaceutical Co. The research involved 1,467 women aged 35-42 undergoing fresh embryo transfers through in vitro fertilization (IVF) and intracytoplasmic sperm injection procedures.

    According to the findings, the TCM formulation produced remarkable results: a relative increase of nearly 23% in live birth rates—considered the gold standard for evaluating assisted reproductive outcomes. The study also documented substantial improvements in positive pregnancy test rates, embryo implantation rates, and clinical pregnancy rates among participants.

    The research was co-led by Professor Yang Dongzi from Sun Yat-sen Memorial Hospital and Professor Zhang Heping from Yale University, representing a collaborative effort between Chinese and international medical expertise.

    Professor Yang emphasized the broader implications: “This TCM medication provides a exemplary model for the modernization and internationalization of traditional Chinese medicine, offering new hope to older families attempting conception.”

    The timing of this breakthrough is particularly significant given demographic trends. National Health Commission data from 2023 reveals that mothers aged 35 and above now constitute over 18.7% of all births in China, with the proportion exceeding 25% in first-tier cities. This shift reflects broader social developments, including changing marriage patterns, evolving childbirth trends, and the implementation of China’s two-child and three-child policies.

    Luo Songping, a nationally distinguished TCM practitioner and professor at the First Affiliated Hospital of Guangzhou University of Chinese Medicine, noted: “The rigorous clinical research design provides reliable evidence-based medical evidence, further supporting TCM’s application value in assisted reproduction.”

    The medication is currently available in mainland China and the Macao market, with researchers planning continued investigation into integrative approaches combining Chinese and Western medical traditions in reproductive medicine.

  • Physician assistants are everywhere. Should you see one?

    Physician assistants are everywhere. Should you see one?

    The American healthcare landscape has witnessed a dramatic transformation over the past quarter-century, marked by the quadrupling of physician assistants within the medical workforce. These medical professionals, often indistinguishable from doctors in their white coats and clinical responsibilities, now represent a significant force in patient care delivery across the nation.

    Originally conceived in the 1960s as an extension of physicians in rural America, P.A.s performed routine tasks under strict medical supervision. Today’s reality reveals a vastly different scenario: these professionals now operate across all medical specialties with considerably greater autonomy. They routinely diagnose conditions, prescribe medications, and manage comprehensive treatment plans, raising important questions about their appropriate role in healthcare.

    The fundamental distinction between doctors and physician assistants lies in their training duration and depth. While physicians complete approximately four years of medical school followed by three to seven years of specialized residency training, P.A.s typically undergo a condensed two-to-three-year master’s program. This educational disparity forms the basis of ongoing professional debates regarding appropriate levels of clinical independence.

    Legal requirements for physician oversight vary significantly by state and specialty. In surgical settings, P.A.s work alongside surgeons but cannot perform major operations independently. In primary care contexts, autonomy expands considerably, with some states permitting remote supervision while others mandate physician presence within specific geographical parameters.

    The American Academy of Physician Associates has actively campaigned for enhanced professional independence, advocating for title modernization from ‘assistant’ to ‘associate’ and lobbying for legislative changes to reduce supervision requirements. The organization contends that increased P.A. autonomy would improve healthcare accessibility and reduce costs. Conversely, the American Medical Association maintains that physician assistants lack equivalent training and that reduced oversight could compromise patient safety.

    Research examining care quality reveals nuanced findings. Studies demonstrate that P.A. integration into medical teams improves healthcare access and reduces treatment delays. Geriatric care models incorporating physician assistants have shown remarkable success, with one study documenting a 38% reduction in hospital visits among nursing home residents. When collaborating directly with physicians—whether in surgical assistance or hospital teams—P.A.s consistently deliver high-quality care. They particularly excel in chronic disease management through regular patient consultations.

    However, research becomes less conclusive regarding diagnostic accuracy in scenarios with minimal physician oversight. Dr. Nicola Cooper of the University of Nottingham notes methodological challenges in quality assessment, as malpractice cases and fatalities remain rare in primary care contexts. Evaluation complexities are compounded by case assignment disparities, where P.A.s often handle less complex presentations than physicians.

    Ultimately, for many Americans in medically underserved areas, the theoretical debate about provider qualifications becomes secondary to practical accessibility. As researcher Roderick Hooker observes, patient satisfaction typically depends on needs being met rather than the specific credentials of the care provider. This reality underscores the evolving discussion about optimal healthcare delivery models in an era of increasing provider diversification.

  • Heart, liver ‘live’ outside body as UAE unveils new system for donor organs

    Heart, liver ‘live’ outside body as UAE unveils new system for donor organs

    Dubai has become the epicenter of a medical revolution with the unveiling of a groundbreaking organ preservation technology that fundamentally alters the race against time in transplant procedures. Announced at the World Health Expo 2026, this advanced perfusion system enables human organs to function externally outside the human body, creating unprecedented opportunities for successful transplants.

    The innovative technology, introduced under the UAE’s national organ donation program ‘Hayat’ through the Emirates Health platform, represents a quantum leap from traditional ice-based storage methods. Rather than merely preserving organs in dormant states, the sophisticated perfusion apparatus actively sustains hearts, livers, and other vital organs in a biologically active condition. This miniature circulatory system meticulously replicates natural blood flow patterns, oxygen absorption mechanisms, and physiological responses—effectively keeping donor organs ‘alive’ during transport and evaluation periods.

    Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MoHAP, emphasized the transformative implications of this technological breakthrough. ‘This advanced technology extends the safe transport window for organs across cities and nations while significantly enhancing preservation quality,’ he stated. The system enables surgeons to monitor real-time functional performance, measure fluid dynamics, and reassess organs previously deemed unsuitable for transplantation—potentially expanding the pool of viable donor organs and recipient candidates.

    Beyond immediate clinical benefits, the technology promises to reshape international healthcare collaboration. Dr. Al Amiri highlighted how the system ‘enhances opportunities for regional and international cooperation in organ exchange’ while strengthening partnerships between medical institutions and research facilities. The integration of smart perfusion devices into the National Centre for regulating Human Organs and Tissues Transplantation is expected to optimize medical resource allocation and improve logistical planning for complex transplant procedures.

    Concurrently, MoHAP showcased the National Genome System—an ambitious precision medicine initiative establishing comprehensive genetic databases to revolutionize disease prevention, diagnosis, and treatment protocols. Together, these advancements position the UAE at the forefront of medical innovation, demonstrating the nation’s commitment to leveraging artificial intelligence and cutting-edge technology in therapeutic applications while reinforcing organ donation as a profound humanitarian value.

  • Healing with horses: Inside Dubai’s new wellness trend

    Healing with horses: Inside Dubai’s new wellness trend

    Dubai’s wellness landscape has welcomed an innovative therapeutic approach at Crystalline Equine, the city’s first boutique sanctuary specializing in equine-facilitated healing. Nestled within JSR Equestrian Centre on the city’s outskirts, this sanctuary offers a stark contrast to Dubai’s fast-paced environment, creating a tranquil space where horses serve as intuitive partners in emotional and physical restoration.

    Founded by Joy Desmond, a former British Airways executive who discovered the therapeutic power of horses during her volunteer work with London-based organization Strength and Learning Through Horses, the center represents a radical career transformation. Desmond’s personal observations of horses helping foster children, neurodivergent youth, and even adult prisoners inspired her vision of combining equine therapy with crystalline energy healing.

    The science behind equine-assisted therapy reveals why these interactions prove so transformative. Horses possess biological sensitivity that makes them exceptional healing partners—their hearts generate electromagnetic fields five times stronger than humans’, and their innate herd dynamics enable them to read human energy and intention with remarkable accuracy. This biological compatibility facilitates co-regulation, where human nervous systems naturally synchronize with equine rhythms, resulting in lowered heart rates, deeper breathing, and muscular release.

    Crystalline Equine’s methodology integrates ground-based interactions with mindfulness practices, somatic awareness, breathwork, and crystal bowl sound healing. Two specially selected horses—Atoll, a retired grand prix jumper providing grounded stability, and Crystalline, an Arabian-Lipizzaner cross embodying elegant presence—move freely throughout sessions, participating according to their intuitive assessment of participants’ needs.

    The therapeutic outcomes observed at the center have been profound. Participants experiencing anxiety, burnout, or trauma—including those with equine-related fears—have demonstrated significant breakthroughs. One notable case involved a woman overcoming decades-long riding accident trauma through gradual exposure, eventually progressing to feeding horses and contemplating riding again.

    Desmond emphasizes the non-directive philosophy underlying their approach: ‘Horses respond to authenticity, not control.’ This principle informs all activities at the sanctuary, where upcoming expansions include Reiki integration allowing horses to intuitively identify areas of emotional density in participants.

    Operating seasonally to honor natural rhythms, Crystalline Equine represents a growing recognition of interspecies healing modalities. Desmond envisions the center evolving into a collaborative hub for horse-assisted practitioners while maintaining its boutique, intentionally holistic approach to wellness that reconnects humans with ancient healing partnerships.

  • Pen-sized electric syringe could mean less pain, faster recovery for cancer patients in UAE

    Pen-sized electric syringe could mean less pain, faster recovery for cancer patients in UAE

    A groundbreaking medical device resembling a writing instrument is poised to transform therapeutic experiences for cancer patients and individuals with diabetic retinopathy across the United Arab Emirates. The innovative ‘aDose Core’ system, developed through advanced engineering research, represents a paradigm shift in targeted drug delivery methodologies.

    This next-generation electro-osmotic pump technology utilizes electrical current to administer ultra-micro doses of medication with unprecedented precision, bypassing traditional bloodstream flooding approaches. The core mechanism operates through a patented ceramic component invented by Japanese scientist Dr. Mamoru Hirafuji, where electrical polarity controls bidirectional fluid movement at nanoliter levels.

    According to Abhishek Choudhary, India Business Manager at atDose Co., Ltd, the technology’s revolutionary nature stems from its departure from mechanical pressure systems. “Unlike conventional syringes that depend on manual force and needle dimensions,” Choudhary explained to Khaleej Times, “this system enables pure voltage-controlled dosage administration, achieving up to 0.05 microliters of drug delivery.”

    The clinical implications are particularly significant for oncology treatments, where direct tumor-site medication administration could dramatically reduce chemotherapy side effects and patient discomfort. Similarly, ophthalmology stands to benefit enormously, with the device capable of delivering therapeutics directly to retinal tissues using ultra-fine needles—a previously unattainable medical achievement.

    The UAE’s substantial investments in oncology and specialized eye care infrastructure position the nation as an ideal adoption market for this technology. Current prototyping focuses on breast cancer applications, with future iterations anticipated to incorporate advanced chips, enhanced reservoir systems, and potential battery-powered functionality.

    Notably, the system maintains compatibility with existing needle designs while featuring a detachable architecture that permits partial sterilization. This thoughtful design approach underscores the technology’s practical orientation toward addressing genuine unmet medical needs rather than simply replacing conventional syringes.

  • UAE imam saved from paralysis after fall; doctors warn against ignoring back pain

    UAE imam saved from paralysis after fall; doctors warn against ignoring back pain

    In a remarkable medical case from Ras Al Khaimah, a 49-year-old Syrian imam narrowly avoided permanent paralysis following a serious fall, demonstrating the critical importance of immediate spinal injury response. Abdul Alchahazie, a long-term UAE resident, suffered a three-meter fall that resulted in severe compression of his vertebral column, with bone fragments directly pressing against his spinal cord.

    RAK Hospital’s medical team sprang into action following the incident, with diagnostic scans revealing an unstable fracture that placed the patient at imminent risk of irreversible neurological damage. Dr. Adnan Shariq, Consultant Neurosurgeon at the facility, emphasized the crucial medical principle guiding such cases: ‘Time is spine.’ He explained that when the spinal cord experiences compression, delayed intervention can result in permanent loss of motor function and sensation.

    The medical team performed urgent minimally invasive surgery to decompress the spinal cord and stabilize the fracture using advanced orthopedic hardware. This prompt intervention proved decisive in Alchahazie’s recovery trajectory. Remarkably, within one week of the procedure, the patient was discharged walking independently without neurological deficits, having undergone intensive physiotherapy.

    This case occurs against the backdrop of global spinal injury statistics from the World Health Organization, which indicates over 15 million people worldwide live with spinal cord injuries, predominantly resulting from preventable trauma. Falls and road accidents constitute the primary causes, followed by violence, occupational hazards, and sports-related incidents.

    Medical professionals stress that the initial 24 hours following potential spinal trauma represent the most critical window for intervention. Symptoms including severe back pain accompanied by numbness, weakness, or mobility difficulties should be treated as medical emergencies. Experts strongly advise against attempting movement after such incidents, recommending instead that patients remain stationary while awaiting trained emergency personnel who can properly stabilize and transport them.

    The successful outcome in this case underscores how coordinated emergency response, rapid diagnosis, and timely surgical intervention can fundamentally alter patient prognosis, potentially determining the difference between complete recovery and lifelong disability.